During the past decade, Minsk City Clinical Oncology Dispensary conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minsk City Clinical Oncology Dispensary" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "AEterna Zentaris" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Jounce Therapeutics, Inc." with 1 trials sponsored and "Kevelt AS" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minsk City Clinical Oncology Dispensary" #1 collaborator was "Belarusian State Medical University" with 1 trials as a collaborator and "Pharmasyntez" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Minsk City Clinical Oncology Dispensary" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Dendritic Cells" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Minsk City Clinical Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "Minsk City Clinical Oncology Dispensary" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AEZS-108 / zoptarelin doxorubicin" (1 trials), "BIBF 1120 plus docetaxel" (1 trials), "BIBW 2992" (1 trials), "Dendritic cells pulsed with MUC-1/WT-1 peptides" (1 trials) and "Dendritic cells pulsed with tumor lysate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Minsk City Clinical Oncology Dispensary" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Minsk City Clinical Oncology Dispensary". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Minsk City Clinical Oncology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Minsk City Clinical Oncology Dispensary, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".